- Home
- FLGC vs HOOK Comparison
FLGC vs HOOK Comparison
Compare FLGC & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGC
- HOOK
- Stock Information
- Founded
- FLGC 2019
- HOOK 2011
- Country
- FLGC United States
- HOOK United States
- Employees
- FLGC N/A
- HOOK N/A
- Industry
- FLGC Biotechnology: Pharmaceutical Preparations
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- FLGC Health Care
- HOOK Health Care
- Exchange
- FLGC Nasdaq
- HOOK Nasdaq
- Market Cap
- FLGC 15.9M
- HOOK 15.3M
- IPO Year
- FLGC 2021
- HOOK 2019
- Fundamental
- Price
- FLGC $0.69
- HOOK $1.19
- Analyst Decision
- FLGC Buy
- HOOK Buy
- Analyst Count
- FLGC 2
- HOOK 4
- Target Price
- FLGC $4.00
- HOOK $10.67
- AVG Volume (30 Days)
- FLGC 116.7K
- HOOK 60.2K
- Earning Date
- FLGC 08-11-2025
- HOOK 08-07-2025
- Dividend Yield
- FLGC N/A
- HOOK N/A
- EPS Growth
- FLGC N/A
- HOOK N/A
- EPS
- FLGC N/A
- HOOK N/A
- Revenue
- FLGC $53,260,000.00
- HOOK $9,351,000.00
- Revenue This Year
- FLGC N/A
- HOOK N/A
- Revenue Next Year
- FLGC N/A
- HOOK N/A
- P/E Ratio
- FLGC N/A
- HOOK N/A
- Revenue Growth
- FLGC N/A
- HOOK N/A
- 52 Week Low
- FLGC $0.42
- HOOK $0.72
- 52 Week High
- FLGC $2.11
- HOOK $6.77
- Technical
- Relative Strength Index (RSI)
- FLGC 55.93
- HOOK 37.08
- Support Level
- FLGC $0.62
- HOOK $1.13
- Resistance Level
- FLGC $0.72
- HOOK $1.25
- Average True Range (ATR)
- FLGC 0.05
- HOOK 0.06
- MACD
- FLGC 0.00
- HOOK -0.01
- Stochastic Oscillator
- FLGC 75.00
- HOOK 26.94
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.